: Polygenic Risk Score Series | Discover Key Considerations for Developing PRS

May 8, 2019

Continue exploring PRSs. Yongyong Shi, a professor at the Bio-X Institute of Shanghai Jiao Tong University, Stewart Macgregor, head of the Statistical Genetics Laboratory at Queensland Institute, Professor of Statistical Genetics David Evans from the University of Queensland, and Gerome Breen, a geneticist at the Social Development and Psychiatry Center at King's College, London, share key considerations researchers should think about when developing a polygenic risk score (PRS), including the need for big data and genome-wide association studies (GWAS). Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on